JRJennifer Ross

Jennifer Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer Ross has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human-porcine transcriptomics reveals resuscitation-responsive pathways in trauma shock

    by Jack S. Gisby, Robert Purcell, Isabella Withnell, Claudia P. Cabrera, David S. Watson, Sara Masarone, Gerard Hernández Mir, Emanuel Savage, Emma Bourne, Eva Wozniak, et al.

    Haemorrhage is the leading preventable cause of trauma death, primarily through ischaemic consequences that current treatments cannot adequately address. We combined human transcriptomic data (n=458) with a controlled porcine model of haemorrhagic shock to identify treatment-responsive molecular mechanisms. Using latent factorisation, we prioritised distinct molecular signatures of the human shock response, including stress signalling, neutrophil activation, and cytotoxic lymphocyte programmes. We assessed the behaviour of these pathways in the experimental porcine system, revealing that shock-initiated immune trajectories are not immutable: blood resuscitation normalised maladaptive transcriptomic changes whilst noradrenaline exacerbated them. While resuscitation modulated neutrophil, heat-shock, and barrier defence programmes, interferon and coagulation pathways were neither mortality-predictive nor treatment-responsive. A factor representing p38-MAPK/AP-1 stress signalling emerged as the dominant mortality-predictive pathway. An in silico small molecule screen identified p38 inhibitors as leading candidates for reversing shock-induced transcriptomic signatures. Our framework identifies modifiable pathways in trauma shock, prioritising p38-MAPK inhibition for therapeutic development and providing a systematic approach for trauma drug repurposing. One sentence summary : Human-porcine cross-analysis reveals treatment-modifiable molecular signatures of trauma shock, identifying potential therapeutic strategies.

  • Open Access

    The hyperacute plasma proteome reports injury severity and defines distinct trauma endotypes

    by Sara Masarone, Gerard Hernández Mir, Jennifer Ross, Jason Pott, Karim Brohi, Michael R. Barnes, Daniel J. Pennington

    The host response to traumatic injury is varied and unpredictable. Patients with subjectively similar injuries progress along divergent clinical paths, from uncomplicated recovery to extended hospitalisation, multiple organ dysfunction, and life-long ill health. The temporal certainty of trauma nonetheless provides immediate opportunity to predict clinical trajectory and intervene therapeutically. We demonstrate using machine-learning that the hyperacute plasma proteome can function as a physiology-driven indicator of injury severity. Moreover, it identifies two serious-injury endotypes that differentially predict unfavourable clinical trajectories. Notably, a prominent neuronal guidance protein signature, that reports vascular dysfunction and immune activation, together with an anti-coagulation/pro-fibrinolytic state, identify those patients who progress to adverse clinical outcomes. Together, these mechanistic insights into immediate host responses to serious trauma reveal tractable targets for future therapeutic interventions.


  • G301(P) Overtreating bronchiolitis: The price to pay for managing sepsis?

    by H Dunlop, J Ross

    Aims The publication of the NICE Sepsis guideline has provided Paediatric Emergency Departments (PED) with an early warning system (EWS) and a default management plan. This allows for identification of almost all cases of sepsis. However, there is a cost. In common with many EWS, the guideline lacks specificity which may result in those without sepsis undergoing unnecessary investigations and treatment. Bronchiolitis is a common presentation. The NICE Bronchiolitis guideline recommends not performing any investigations or treatments in almost all cases. As such, there is risk that children presenting with bronchiolitis will be over investigated and overtreated is considered at risk of sepsis. Methods We identified 200 consecutive infantsResults 213 patients were identified, 13 were excluded due to an incomplete nursing triage. Of the 200 patients: 100 infants (50%) had at least one high risk criteria (stratified as high risk of sepsis) 43 (21.5%) had more than one criteria The most common criteria was tachycardia (39.5%). Of the sickest group (43 with more than one criteria): 19 (44.2%) admitted, 9 (21.9%) blood tests 4 (9.3%) intravenous antibiotics (allConclusion 50% of infants with bronchiolitis were stratified as high risk. The NICE Sepsis guideline, being a default management plan bolted on to an EWS, may potentially result in inappropriate antibiotics and unnecessary investigations being performed. To deviate from the default management plan requires review by a senior clinical decision makes (ST4 or above). This review may represent a logistic challenge in many busy PED making the default plan, antibiotics and all, the path of least resistance. While this is the strength of the guideline in managing sepsis, quantifying the harm it may cause in other conditions is key.